Ustekinumab is a human monoclonal antibody used to treat psoriasis.
It is manufactured in the Netherlands. It is directed against interleukin 12 and interleukin 23, naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders.
Related Products:
Alirocumab; Denosumab; Eculizumab; Evolocumab; Omalizumab; Vedolizumab; Trastuzumab; Omalizumab; Nivolumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept